+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Induction of ventricular fibrillation during antiarrhythmic drug treatment predicts sudden death in patients with sustained monomorphic ventricular tachycardia or ventricular fibrillation after myocardial infarction



Induction of ventricular fibrillation during antiarrhythmic drug treatment predicts sudden death in patients with sustained monomorphic ventricular tachycardia or ventricular fibrillation after myocardial infarction



Circulation 90(4 Part 2): I455




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031908049

Download citation: RISBibTeXText


Related references

Induction of ventricular fibrillation, but not of sustained monomorphic ventricular tachycardia predicts sudden death in patients on amiodarone because of ventricular tachyarrhythmias after myocardial infarction. Journal of the American College of Cardiology 0(SPEC ISSUE): 280A, 1994

Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction. Heart 75(1): 23-28, 1996

Electrophysiologic variables characterizing the induction of ventricular tachycardia versus ventricular fibrillation after myocardial infarction: Relation between ventricular late potentials and coupling intervals for the induction of sustained ventricular tachyarrhythmias. Journal of the American College of Cardiology 21(7): 1624-1631, 1993

Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy. Heart Rhythm 12(10): 2106-2114, 2016

Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. American Journal of Cardiology 71(10): 823-826, 1993

Antiarrhythmic Efficacy of Oral Sotalol in Patients with Sustained Ventricular Tachycardia or Ventricular Fibrillation Postmyocardial Infarction. Journal of Cardiovascular Electrophysiology 3(2): 95-100, 1989

Ventricular fibrillation and sustained monomorphic ventricular tachycardia induction characteristics during programmed stimulation. Circulation 78(4 Part 2): II71, 1988

Do any patients treated with amiodarone for sustained ventricular tachycardia ventricular fibrillation have an acceptably low risk of sudden death. Circulation 82(4 Suppl. 3): III83, 1990

Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients. American Journal of Cardiology 62(16): 1124-1125, 1988

Long-term results of amiodarone therapy in patients with sustained ventricular tachycardia or ventricular fibrillation for prevention of cardiac sudden death. Japanese Circulation Journal 58(Suppl. 4): 1309-1312, 1994

Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia of ventricular fibrillation risk stratification based on clinical variables. American Journal of Cardiology 55(4): 372-374, 1985

Prediction of sudden death and sustained ventricular tachycardia after acute myocardial infarction Which patients should undergo programmed ventricular stimulation?. European Heart Journal 14(ABSTR Suppl. ): 280, 1993

Signal averaged electrocardiogram and inducible sustained monomorphic ventricular tachycardia in myocardial infarction patients without clinical ventricular tachycardia. Circulation 84(4 Suppl.): II648, 1991

Relation between ventricular arrhythmia and sudden cardiac death in patients with acute myocardial infarction: the predictors of ventricular fibrillation. Journal of the American College of Cardiology 8(1 Suppl A): 69a-72a, 1986

Incidence and timing of recurrences of sudden death and ventricular tachycardia during antiarrhythmic drug treatment after myocardial infarction. American Journal of Cardiology 69(17): 1403-1406, 1992